Skip to main content

Peer Review reports

From: γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments

Original Submission
23 Apr 2014 Submitted Original manuscript
24 Apr 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 2
24 Apr 2014 Submitted Manuscript version 2
11 Jun 2014 Author responded Author comments - Andrew Massey
31 May 2014 Reviewed Reviewer Report - Alan Eastman
2 Jun 2014 Reviewed Reviewer Report - Hatim Allawi
Resubmission - Version 3
11 Jun 2014 Submitted Manuscript version 3
Publishing
30 Jun 2014 Editorially accepted
4 Jul 2014 Article published 10.1186/1471-2407-14-483

You can find further information about peer review here.

Back to article page